OhioHealth’s fiscal 2026 margin narrowed as divestiture gains disappeared
OhioHealth closed fiscal 2026 with operating income of $610.2 million, translating to an 8.2% margin, down from $702.6 million and a 10.1% margin in the prior year. The decline came even as the Columbus-based system expanded its top line, a reminder that hospital financial performance can move in opposite directions when growth in core patient care is offset by changes in one-time items and rising operating costs.
The most important reason for the year-over-year drop was simple: the system did not record a gain on business divestitures in fiscal 2026. In the previous fiscal year, OhioHealth booked $316.6 million tied to the sale of its home health and hospice business and its outreach laboratory business, and that gain was recorded as operating revenue. Once that unusual boost disappeared, the operating comparison reset to a more ordinary view of the enterprise.
Revenue growth stayed strong in the core business
Even without the divestiture windfall, OhioHealth’s core operating performance improved on the revenue side. Total operating revenue reached $7.4 billion in fiscal 2026, up 6.6% year over year. Patient service revenues climbed 11.8% to $7.1 billion, while other revenues rose 10.7% to $347.2 million.
Those gains matter because they suggest continued demand across the system’s clinical footprint, with patient care activity doing more of the financial work. In a health system, patient service revenue is usually the clearest reflection of volume, acuity, payer mix, and the ability to capture reimbursement for clinical work already being delivered. The increase points to a healthier underlying revenue engine, even if the final operating margin softened after the prior year’s exceptional items were stripped away.
A one-time gain can inflate a year’s results; steady patient service revenue tells a different story.
Expense growth moved faster than the operating base
Operating expenses rose at a faster pace than revenue. OhioHealth reported total operating expenses of $6.8 billion in fiscal 2026, up 8.8% from $6.3 billion in fiscal 2025. Salaries and wages were $3.1 billion, compared with $3 billion the year before.
For a large integrated health system, payroll is rarely a small line item. Labor costs shape everything from inpatient throughput to outpatient access, and the rise in salaries and wages signals continued pressure across the clinical workforce. Even in a year when revenue advanced, expense inflation can blunt the benefit quickly. Higher staffing costs also tend to reflect the reality of operating a system that must recruit, retain, and schedule nurses, technicians, pharmacists, physicians, and support staff across multiple care settings.
The financial picture is therefore not a story of weakness so much as a story of compression. OhioHealth produced more operating revenue, but it also carried a heavier expense load, leaving less room for margin expansion once the prior year’s divestiture-related boost fell away.
Surgery center partnerships added another strategic layer
OhioHealth also deepened its ambulatory footprint in fiscal 2026. The system entered into a partnership agreement with a surgery center and became the controlling partner in two prior equity method surgery center joint ventures. It also recorded $13.3 million in proceeds from the sale of joint ventures, although the report did not specify which ventures were sold.
That movement into surgery center control is clinically meaningful, not just financially relevant. Ambulatory surgery continues to pull procedures out of the hospital setting when case mix, payer dynamics, and patient acuity allow. Gaining control of joint venture surgery centers can help a health system shape where procedures occur, how efficiently they are scheduled, and how much of the downstream perioperative revenue remains inside the organization. The strategy also gives the system more influence over outpatient surgical access, which can matter for patients waiting on elective orthopedic, ophthalmologic, gastrointestinal, and other procedures commonly performed outside the main hospital campus.
The financial effect may not show up all at once, but the direction is clear. OhioHealth is positioning itself for a larger role in outpatient procedural care, a setting that has become central to health system strategy as more cases migrate away from higher-cost inpatient sites.
Net income stayed high despite the operating reset
OhioHealth’s net income was $1.5 billion for the year ended June 30, 2026, down from $1.6 billion in fiscal 2025. Long-term debt stood at $1.6 billion as of June 30, 2026, roughly unchanged from the previous year.
The near-flat debt profile suggests the system did not materially change its long-term leverage in fiscal 2026, even as it continued to adjust its portfolio and broaden control over ambulatory surgery assets. Stability on the debt side can provide operating flexibility, especially during periods when labor costs remain elevated and capital needs compete with margin pressure. Net income also remained robust, though the year-over-year dip reflects the same issue seen in operating income: the system was being compared against a prior year that benefited from a major divestiture gain.
For hospital finance observers, the more durable takeaway is not the headline net income figure. It is the combination of stronger patient service revenue, higher operating costs, and an active reshaping of business lines. Those forces create a more complex picture than a simple margin decline or profit increase would suggest.
What the numbers say about the next fiscal year
OhioHealth entered fiscal 2026 with a stronger revenue base and a less favorable comparison point. The system still grew, but the prior year’s divestiture gain created a high bar that could not be repeated, and expense growth narrowed the spread between revenue and cost. In parallel, the move deeper into surgery center ownership shows a health system aligning itself with outpatient procedural growth rather than relying solely on hospital-based services.
For patients, that shift can translate into more care delivered closer to home and in lower-intensity settings when clinically appropriate. For the system, it represents a bid to preserve procedural volume and revenue as the site of care continues to migrate.
The next financial cycle will show whether that ambulatory strategy can offset labor pressure and whether core patient service revenue continues to outpace expenses without the help of large divestiture-related gains. For now, OhioHealth’s fiscal 2026 report shows a system with a still-strong operating base, thinner margins, and a growing stake in outpatient surgery.